Page 1506 - Clinical Small Animal Internal Medicine
P. 1506

1444  Section 12  Skin and Ear Diseases

            to the lungs, lymph nodes, and abdominal viscera has   and prednisone has also been reported to induce a tem-
  VetBooks.ir  been reported in up to 91% of cases. Affected dogs are   porary response.
            usually presented for lameness or a soft tissue swelling.
            In dogs with disseminated HS, the clinical signs are
                                                              In general, the prognosis is poor. Dogs with localized
            vague and include anorexia, lethargy, and weight loss.   Prognosis
            Pulmonary involvement is common and dogs may show   HS receiving aggressive localized treatment and sys-
            evidence of dyspnea at the time of initial presentation.   temic chemotherapy may have a better prognosis with
            Neurologic abnormalities, including ataxia and parapa-  a median survival time of 568 days. The median sur-
            resis, are also common. Other organs often affected   vival  time  for  dogs  with  disseminated  HS  receiving
            include the liver and spleen. Although clinicopathologic   chemotherapy is 106 days. The presence of distant
            findings are nonspecific, anemia, thrombocytopenia,   metastasis or disseminated disease worsens the prog-
            and hypoalbuminemia were consistently reported in   nosis. Many dogs are euthanized at the time of diag-
            cases of hemophagocytic HS. Diffuse splenomegaly   nosis because of poor clinical condition and poor
            with ill‐defined masses was also consistently present in   prognosis.
            these cases.

            Diagnosis                                           Sterile Nodular Panniculitis
            The diagnosis is based on clinical signs, signalment, and
            cytologic and histopathologic findings. The main clini-  Panniculitis refers to inflammation of the subcutane-
            cal differential diagnoses are other neoplasias and sys-  ous fat and it may be associated with a variety of con-
            temic histiocytosis. Both localized and disseminated HS   ditions.  Sterile  nodular panniculitis (SNP) refers  to
            have the potential for highly aggressive behavior so   sterile inflammation of the subcutaneous fat tissue of
            complete staging to determine disease extent is recom-  unknown origin. Clinical signs include single or mul-
            mended to determine possible treatments and progno-  tiple  subcutaneous  nodules,  intermittent  fever,  and
            sis. Cytologic finding include large round cells with   anorexia.
            foamy cytoplasm and multinucleated giant cells admixed   Concurrent inflammation of the fat in other organs
            with spindle‐shaped cells. Histopathologically, the tumors   can be seen in cases of SNP. Skin lesions can be solitary
            are poorly demarcated and the neoplastic infiltrate con-  or multiple and multiple lesions can be associated with
            sists of pleomorphic mononuclear cells and multinucleated   systemic signs including fever, lethargy, and anorexia.
            giant cells. Phagocytosis of neutrophils and erythro-
            cytes is not uncommon. Marked anisokaryosis and
            anisocytosis with high mitotic rate are also present. The   Pathogenesis
            histopathologic findings and the use of immunohisto-
            chemical staining help differentiate these tumors from   Sterile nodular panniculitis has been documented in
            other round cell tumors.                          association with systemic lupus erythematosus, pancrea-
              Recently, a screening program has been proposed for   titis and pancreatic tumors, rheumatoid arthritis, and
            early detection of disseminated HS in Bernese mountain   lymphoplasmacytic  colitis. In people, a  deficiency of
            dogs. The program suggests screening of Bernese moun-  alpha‐1‐antitrypsin, a protease inhibitor, has been sug-
            tain dogs over 4 years of age every six months, including   gested to be a predisposing factor. In dogs, this associa-
            diagnostic imaging and measurement of ferritin as a   tion has not been made with certainty. In one dog with
            blood‐borne marker of the disease.                panniculitis in which alpha‐1‐antitrypsin was found to
                                                              be low, a Bartonella infection was present, making it dif-
            Therapy                                           ficult to determine the cause. In one retrospective study,
            For cases of localized HS, improved outcome has been   37% (16/43) of the patients had prior surgery with lesions
            reported with the use of localized therapy, including sur-  developing at the surgery site.
            gery and radiation therapy. Unfortunately, the rate of
            metastasis is very high (up to 91%) so the use of adjuvant   Signalment
            systemic therapy may be beneficial. The disseminated
            form of the disease usually has poor sensitivity to chem-  A large retrospective study did not identify any age,
            otherapy. Lomustine, doxorubicin, and vincristine have   breed or sex predilection; however, others suggest 3–5
            been used with variable success. The use of bisphospho-  years as the most common age of onset and dachshunds,
            nates has been proposed to increase the effectiveness of   miniature poodles, and collies as the breeds at increased
            chemotherapy against HS cells. The use of a multiple   risk for SNP. In two studies, the most affected dogs were
            drug protocol including cyclophosphamide, vincristine,   neutered, suggesting no gender predilection.
   1501   1502   1503   1504   1505   1506   1507   1508   1509   1510   1511